An observational study to gather information on the safety and effectiveness of the BeFlow Iliac covered stent system in the treatment of patients.
Résumé de l'étude
This study is designed to gather information on the safety and effectiveness of the BeFlow covered iliac stent system, a medical device used to treat obstructions in the iliac arteries (the large blood vessels in the lower abdomen and legs). The device is used to improve blood flow in patients with narrowed or obstructed arteries due to a condition called atherosclerosis or other similar disorders. The primary objective of the study is to evaluate the effectiveness of the BeFlow stent in treating these obstructions and to monitor any risks or side effects over time. The study involves collecting data from patients who have already had the BeFlow stent implanted; this information will then be reviewed to determine the safety and effectiveness of the device. They will be asked to sign an informed consent form, and their progress will be monitored through regular check-ups, including ultrasounds and tests to monitor their health status. The results of this study will help doctors understand the effectiveness of the BeFlow stent and ensure its safety for long-term use in the treatment of arterial obstructions.
(BASEC)
Intervention étudiée
Endovascular treatment with the BeFlow covered iliac stent system involves the insertion of a stent (a mesh tube) into the iliac artery to keep the narrowed or obstructed blood vessel open. This helps improve blood flow in the pelvic area and reduces symptoms caused by stenosis (narrowing) of the artery.
(BASEC)
Maladie en cours d'investigation
Iliac artery stenosis occurs when the blood vessels in the lower abdomen and legs narrow, reducing blood flow. This can cause pain or cramping in the legs, especially when walking, as the muscles do not receive enough blood.
(BASEC)
1. Patients with an indication for permanent intraluminal placement in the iliac arteries to restore and improve patency compromised by atherosclerosis or other stenoses that have been or will be treated with stents, according to the instructions for use of the BeFlow covered iliac stent. 2. The patient is able and willing to sign the informed consent. 3. Patients aged 18 years or older at the time of consent. (BASEC)
Critères d'exclusion
1. Patients with any contraindications listed in the Instructions for Use. 2. Previous stenting in the target vessel. (BASEC)
Lieu de l’étude
Lugano
(BASEC)
Sponsor
Bentley InnoMed GmbH Richard Griesbach
(BASEC)
Contact pour plus d'informations sur l'étude
Personne de contact en Suisse
Elien Vernez
+ 32 (0) 52 25 27 45
office@clutterid3medical.comID3 medical
(BASEC)
Informations scientifiques
non disponible
Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)
Commission cantonale d'éthique du Tessin
(BASEC)
Date d'approbation du comité d'éthique
01.10.2025
(BASEC)
Identifiant de l'essai ICTRP
non disponible
Titre officiel (approuvé par le comité d'éthique)
An international, multi-centre observational study registry to evaluate safety, performance, and clinical benefit of the BeFlow Iliac Covered Stent System. (BASEC)
Titre académique
non disponible
Titre public
non disponible
Maladie en cours d'investigation
non disponible
Intervention étudiée
non disponible
Type d'essai
non disponible
Plan de l'étude
non disponible
Critères d'inclusion/exclusion
non disponible
non disponible
Critères d'évaluation principaux et secondaires
non disponible
non disponible
Date d'enregistrement
non disponible
Inclusion du premier participant
non disponible
Sponsors secondaires
non disponible
Contacts supplémentaires
non disponible
ID secondaires
non disponible
Résultats-Données individuelles des participants
non disponible
Informations complémentaires sur l'essai
non disponible
Résultats de l'essai
Résumé des résultats
non disponible
Lien vers les résultats dans le registre primaire
non disponible